• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Quality

    FDA Letter To Daiichi Takes Aim At Turalio Patient Video

    FIERCE PHARMA

    US FDA declines to approve Merck-Daiichi`s `guided missile` cancer drug

    REUTERS

    FDA rejects Merck`s first ADC in Daiichi partnership

    FIERCE PHARMA

    EMA committee rejects Daiichi Sankyo`s MAA for quizartinib

    PHARMABIZ

    Federal Circuit Rules that a Statutory Patent Disclaimer is Sufficient to Trigger Hatch-Waxman DJ Jurisdiction; Will It Be Enough to Trigger a Forfeiture of 180-Day Exclusivity?

    FDA LAW BLOG

    Apotex Inc. v. Daiichi Sankyo, Inc.

    PATENT DOCS

    Doctor Outreach at Heart of Daiichi Sankyo`s $39M Settlement with DoJ

    FIERCE PHARM ASIA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.